Gut Barrier Panel
KBMO's Gut Barrier Panel now includes LPS as well as Candida, Zonulin and Ocludin
The panel now has 8 different ways to identify Leaky Gut and is included with the FIT 132 and FIT 176 and available as a standalone fingerstick kit
KBMO is excited to announce the Gut Barrier Panel (GB Panel); this is included with the FIT 176 and FIT 132 Tests. Providers who strive to differentiate the levels of gut dysfunction, from simple sensitivity to inflammation, and more extreme levels of leaky gut will find the addition of the GB Panel very useful.
Gut Barrier Panel (GB Panel)
KBMO has created a unique Gut Barrier Panel which in recognition that leaky gut occurs across a spectrum we have included the following gatekeeper markers: Candida, Zonulin, Occludin and Lipopolysaccharides (LPS). For each marker, we measure IgG 1-4 /C3d in addition to IgA 1 and 2.
Candida
We measure and use any candida overgrowth in the stomach/dysbiosis as a precursor to leaky gut occurrence.
Zonulin
Zonulin is a marker of intestinal permeability, otherwise known as leaky gut. If a patient has elevated Zonulin levels, the normal regulation of the tight junctions is compromised. This Zonulin marker is unique to KBMO please follow the link for more information: https://kbmodiagnostics.com/zonulin-test
Occludin
Occludin is a marker of tight junction stabilization and optimal barrier function. Elevated occludin indicates that the tight junctions are breaking down.
Lipopolysaccharides (LPS)
LPS is a major structural component of the outer membrane of gram-negative bacteria. Elevated levels of antibody against LPS may be indicative of Leaky Gut Syndrome and other gastrointestinal inflammatory diseases.
GB Panel Interpretation
If any of the 8 markers are positive, we recommend to consult your provider with regards a gut healing protocol.
The GB Panel removes the guesswork; providers no longer have to guess they can test for Food Sensitivities, Inflammation and Leaky Gut and then treat their patients accordingly.
This Panel is included with the FIT 132 and FIT 176. It will also be available as a standalone fingerstick test.
Please listen to Dr Robert Silverman discuss the interpretation of the Gut Barrier Panel
KBMO in partnership with Fullscript gives practitioners a convenient platform for prescribing, dispensing, and managing healtcare’s best supplements, with personalized tools and support to inspire better patient engagement.
